News

Starting HPV vaccination earlier improves access, builds trust with families, and increases uptake before virus exposure to prevent cancer.

A study found that more than two-thirds of adolescents with congenital heart disease experience at least one cardiac or noncardiac comorbidity.

Samina Ali, MD, reports that ibuprofen alone provides pain relief comparable to combination regimens for acute limb injuries vs opioids.

New phase 3 trial data reveal fremanezumab's effectiveness and safety for preventing migraines in children, offering a vital treatment option.

Children hospitalized for bronchiolitis who received high-flow nasal cannula therapy were more likely to be diagnosed with asthma in early childhood.

The phase 3 SPACE trial showed fremanezumab reduced monthly migraine days vs placebo in pediatric patients with episodic migraine.

An acceptance and commitment therapy–based parenting program significantly reduced parental stress compared with usual care.

Phase 3 SCOUT-HCM results showed mavacamten significantly reduced LVOT gradient vs placebo in adolescents with obstructive HCM.

This recent FDA clearance expands the use of the iotaSOFT Insertion System for pediatric use.

A study found that nonmedically indicated formula supplementation among term infants is common and increasing over time.

Experts say recent CDC vaccine schedule changes may complicate clinician–family communication without altering the underlying evidence supporting pediatric vaccination.

New AAP guidance affirms mother’s own milk as optimal for very low birth weight infants, citing reduced NEC and infection risk and outlining donor milk use.

Young adult and adolescent survivors of childhood cancer exhibit accelerated epigenetic aging associated with worse neurocognitive outcomes.

The approval marks the first treatment for this neurodegenerative with a low survival rate beyond 3 years.

Katie McMahon and Kathy Baylis, PhD, discuss research showing that prenatal exposure to hot, humid conditions has significant effects on child growth and health.

Multiple adverse prenatal exposures have been linked to lasting behavioral problems and altered brain development through adolescence.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Maternal influenza and TDaP vaccination during pregnancy was associated with fewer influenza- and pertussis-related hospital and ED visits in infants younger than 6 months.

Mimi Lee, MD, PhD, noted that broader use of genomic testing could allow pediatric care to move beyond symptom-based diagnoses toward individualized treatment strategies.

The Phase 3 Beeline trial has begun dosing patients to evaluate radiprodil, a targeted NMDA receptor modulator designed to address the underlying biology of GRIN-related neurodevelopmental disorder.

Findings from a phase 2 trial showed that once-weekly TransCon CNP plus TransCon hGH produced durable growth and proportionality benefits in children with achondroplasia.

New dietary guidelines stress whole foods and reduced processing, with expanded, age-specific guidance for infants, children, and adolescents.

Shilpa Patel, MD, MPH, says pediatricians can effectively lead asthma care by emphasizing education, trust, and frequent reassessment.

ACIP recommends use of GSK’s pentavalent MenACWY-CRM/MenB-4C vaccine when MenACWY and MenB are indicated at the same visit.

New research shows COVID-19 vaccination before or during pregnancy significantly lowers the risk of severe maternal illness and reduces rates of preterm birth.

GLP-1 receptor agonist use was associated with a lower risk of asthma exacerbations in adolescents with overweight or obesity.

According to Fleischer, epicutaneous immunotherapy represents a “marathon, not a sprint,” with potential long-term benefits when started young.

Results from a large randomized trial found that a midpregnancy blood test paired with targeted interventions improved neonatal outcomes in low-risk pregnancies.